HUG Meeting 13 - 15 September 2005 , Brussels

Presentations

Day 1 - 13th September 2005

Introduction to the HUG, Miodrag Mitic, GS1
HUG Work Plan, Ulrike Kreysa, GS1
HUG work team: Membership, Volkar Zeinar, B.Braun
HUG work team: Regulatory Affairs, Jackie Elkin, Medtronic
HUG work team: Standards Implementation, Tom Werthwine, Manager, AIDC Technology and Industry Standards, Johnson & Johnson
HUG work team: Standards Development , Peter Tomicki, Baxter
HUG work team: Business Case, Ed Dzwill, Johnson & Johnson Pharma
HUG work team: Communication & Coordination, Rich Hollander, Pfizer

Day 2 - 14th September 2005

The HUG - Mission and Vision, Rich Hollander, Pfizer
Counterfeit Medicines, Dr. Hans-Georg Wagner, Head of Unit Communications and Networking, European Medicines Agency (EMEA), London
Strategies to Combat Counterfeit Activities in the EU, Sabine Atzor, European Commission, Enterprise and Industry Directorate-General, Consumer Goods, Unit F2 Pharmaceuticals, Brussels
Dr. Marianne Takki, European Commission, Public Health Directorate, Health Strategy, Brussels (Presentation not available)
Food and Drugs Administration (FDA) Update, Michelle Limoli, Associate Director, Office of International Programs U.S. Food and Drug Administration (FDA), Washington, USA
The drugs tracking system in Italy, Dr. W. Bergamaschi, Director General for Information Science System and Statistics, Italian Ministry of Health, Rome
Developing Policy On Machine Readable Codes On Medicines In England, Prof. David Cousins, Head of Safe Medication Practice, NHS National Patient Safety Agency, London
Product Identification, Jesus Gavira Sanchez, General Administration of Economic Management, Regional Healthcare Service Area of Andalusia
Overview of GS1 Healthcare activities in Europe, Jim Bracken, CEO, GS1 Ireland
Overview of GS1 Healthcare activities in North America, John Roberts, Director Healthcare, GS1 US
Overview of GS1 Healthcare activities in Japan , Yamoto Miyahara, General Manager, GS1 Japan